肠系膜Castleman病在18F-FDG PET/CT上被误诊为直肠癌淋巴结转移
一名64岁男性因直肠癌分期行18F-FDG PET/CT,发现高代谢直肠病灶、代谢活跃的肠系膜淋巴结及轻度FDG摄取的肺结节,高度怀疑转移。手术及多周期化疗后随访PET/CT示除肠系膜淋巴结增大且代谢增高外其余病灶缓解,血清CEA正常,术后病理证实肠系膜淋巴结为Castleman病。
要点
- 直肠癌分期PET/CT中肠系膜高代谢淋巴结并非均为转移,Castleman病可表现为FDG高摄取。
- 随访中CEA正常而淋巴结代谢增高,提示需考虑良性病变可能。
- 术后病理是鉴别肠系膜淋巴结性质的关键。
核心结论
- 肠系膜Castleman病可在18F-FDG PET/CT上表现为高代谢淋巴结,易被误诊为直肠癌淋巴结转移。
研究设计与样本
- 本文为病例报告,报道一名64岁男性直肠癌患者行18F-FDG PET/CT分期及后续随访的过程。
主要发现
- 初始PET/CT除高代谢直肠病灶外,显示肠系膜淋巴结代谢活跃及多发肺结节伴轻度FDG摄取,高度怀疑转移。
- 手术及多周期化疗后随访PET/CT示除肠系膜淋巴结增大且代谢活性更高外,其余病灶均缓解。
- 随访期间血清CEA保持正常,术后肠系膜淋巴结病理证实为Castleman病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Two years ago, a 64-year-old man underwent an 18 F-FDG PET/CT for staging rectal cancer. Besides the hypermetabolic rectal lesion, the image revealed a mesenteric lymph node with intense activity and multiple lung nodules with slight FDG uptake, which were highly suspected of metastases. After surgery and multiple cycles of chemotherapy, the follow-up 18 F-FDG PET/CT showed remission of all lesions except for the enlarged mesenteric lymph node with higher metabolic activity. Serum CEA remained normal during the follow-up. Postoperative pathology of the mesenteric lymph node confirmed Castleman disease.
引用
- Liu M, Zhou J, Zhu W, et al. Mesenteric Castleman Disease Misdiagnosed as Lymph Node Metastasis of Rectal Cancer on 18 F-FDG PET/CT. Clin Nucl Med. 2023. PMID: 37703486. doi:10.1097/RLU.0000000000004832
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。